(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

SEMAGLUTIDA, SEUS USOS, E COMPOSIÇÃO FARMACÊUTICA

IndeferidaInvention PatentPCT · EP2017060160
Talk to an expert

Application data

Number

112018072020

Type

Invention Patent

Filing

04/28/2017

Publication

02/12/2019

PCT

EP2017060160
View on INPI

Progress at the INPI

Under appeal
  1. Filing04/28/17
  2. Publication02/12/19
  3. Examination
  4. Refused06/23/26
  5. Grant
  6. In force

The application was refused by the INPI on 06/23/2026. The invention was never patented.

Talk to a specialist

Latest action published by the INPI: 06/23/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

NOVO NORDISK A/S

DK

See this company's full portfolio

Inventors

O. H. (pessoa física)

NO

Technical data

IPC Classification

A61K 38/26A61P 3/10A61P 9/00

Priority claims

EP

16167458.5 · 04/28/2016

EP

16188262.6 · 09/12/2016

Abstract

A presente invenção refere-se ao agonista do receptor de GLP-1, semaglutida, para uso na medicina.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Indeferimento

#9.2

06/23/2026

RPI 2894

Conhecimento de parecer técnico

#7.1

03/17/2026

RPI 2880

15.50

O pedido foi dividido no BR122025010585-6 protocolo 870250043258 em 26/05/2025 16:33.

07/01/2025

RPI 2843

15.50

O pedido foi dividido no BR122022025361-0 protocolo 870220116295 em 12/12/2022 16:31.

01/31/2023

RPI 2717

Parecer de pré-exame

#6.23

09/20/2022

RPI 2698

Adição na publicação

#15.35

09/08/2021

RPI 2644

Notificação de entrada na fase nacional - PCT

#1.3

02/12/2019

RPI 2510

Alteração de dados cadastrais

#1.1

11/06/2018

RPI 2496

Related

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.